The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.
Must be at least 18 years of age
Be able to provide consent
Presenting for planned procedures that require percutaneous venous punctures, such as atrial fibrillation radiofrequency ablation, and where the physician utilizes a LockeT device or MC to close the wound.
Under the age of 18
Unable to or unwilling to provide consent
Cannot comply with study requirements
Not undergoing procedures that require a percutaneous venous puncture or planned access to the left atrium and/or ventricle